Secondary Buyout • Business Services

Argan Capital Exits Humana

On January 14, 2019, private equity firm Impilo invested in business services company Humana from Argan Capital

Investment Context
  • This is Impilo’s 1st transaction in the Business Services sector.
  • This is Impilo’s 2nd transaction in Sweden.

Explore All 831 Secondary Buyout Business Services Deals - Search the Database Free


Investment Summary

Date January 14, 2019
Target Humana
Sector Business Services
Investor(s) Impilo
Sellers(s) Argan Capital
Deal Type Secondary Buyout

Target Company

Humana

Stockholm, Sweden
Humana is a provider of personal assistance and related services for individuals with functional impairments. The Company’s offering encompasses a wide variety of services for individuals with functional impairments, including providing personal assistants, legal assistance, administrative support, assistant recruitment, and training. Humana was founded in 2000 and is based in Stockholm, Sweden.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

DESCRIPTION

Impilo is a private investment firm focused exclusively on on investments in Nordic companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Impilo prefers majority investments, but will consider select minority situations. Target companies are generally valued between SEK 200 million and SEK 1.5 billion. Impilo has offices in Stockholm and Copenhagen.


Deal Context for Investor #
Overall 4 of 10
Sector: Business Services 1 of 1
Type: Secondary Buyout 1 of 2
Country: Sweden 2 of 4
Year: 2019 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-07-30 Immedica Pharma

Stockholm, Sweden

Immedica Pharma provides commercialization and distribution of orphan and niche specialty pharmaceuticals across Europe and the Middle East. Immedica Pharma was founded in 2018 and is based in Stockholm, Sweden.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-03-28 TFP Fertility

Oxford, United Kingdom

TFP Fertility is a provider of IVF and related fertility services with c. 24,000 cycles annually, incl. adjacent services. TFP comprises 19 clinics across the UK, Germany, Austria, Denmark, the Netherlands and Poland, and a sperm bank, a blood lab and c. 80 ultrasound sites across the UK. TFP is based in Oxford, England.

Buy -

Seller Profile 1

SELLER

Argan Capital

Lancing, United Kingdom

Investor Investor Investor Investor


Category Private Equity Firm
Founded 2006
PE ASSETS 425M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Argan Capital is an independent private equity firm focused on acquiring mid-sized European companies. Broad areas of interest include the industrial, service and consumer sectors. Prospective companies generally have strong management in place, sustainable cash-flows, competitive advantages, and the 'potential for value enhancement'. Argan targets businesses enterprise valued from €50 to €150 million. Argan Capital was formerly the European private equity arm of Bank of America, and became independent in 2006. The Firm is based in London.


Deal Context for Seller #
Overall 6 of 6
Sector: Business Services 1 of 1
Type: Secondary Buyout 5 of 5
Country: Sweden 1 of 1
Year: 2019 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-11-02 Hortex

Warsaw, Poland

Hortex is committed to creating frozen food, juices, nectars and drinks, that are becoming increasingly efficient in satisfying consumer needs. Hortex have been creating new trends, making up innovative product categories, adjusting to lifestyle change. Hortex was founded in 1958 and is based in Warsaw, Poland.

Sell -